• Contact info@abtriva.com for inquiries and orders.
  • Chinese (Simplified)

  • English

  • German

  • Korean

  • Spanish

United States (English / $ USD)

Recombinant Human Cytokine receptor-like factor 3 (CRLF3)

ACP02085

Number
Order Exclusive Products Now

Request a Quote
High Purity LevelsPrecision and ReliabilityCustomization Options

Specifications


Cat.No ACP02085 Target NameCRLF3
Target SynonymsCytokine receptor-like molecule 9 (CREME-9) (Cytokine receptor-related protein 4) (Type I cytokine receptor-like factor p48)FormLiquid or Lyophilized powder
Expression SystemE.coliExpression Range1-442aa
Mol Weight57.2 kDaProtein LengthFull length
PurityGreater than 90% as determined by SDS-PAGE.Storage Buffer5%-50% glycerol. Lyophilized powder form: the buffer before lyophilization is Tris/PBS-based buffer, 6% Trehalose, Liquid form: default storage buffer is Tris/PBS-based buffer, pH 8.0.

Immunogen Information


Target SpeciesHumanUniprot IDQ8IUI8
Background Information
  • Uniprot Id

    Q8IUI8

  • Target Species

    Human

  • Target Name

    CRLF3

  • Target Full Name

    Cytokine receptor-like factor 3

  • Target Function

    May play a role in the negative regulation of cell cycle progression.

  • Target Subcellular Location

    Cytoplasm.

  • Target Protein Families

    Cytokine receptor-like factor 3 family

  • Target Tissue Specificity

    Expressed in several embryonic and adult tissues, including adult and fetal brain, liver, spleen and pancreas. Expressed in adult, but not fetal kidney. Expressed in skin and squamous cell carcinoma (SCC) and in several other cancer types. Also detected i

  • Target Research Area

    Immunology

  • Target Synonyms

    CRLF3; CREME9; CRLM9; CYTOR4; P48Cytokine receptor-like factor 3; Cytokine receptor-like molecule 9; CREME-9; Cytokine receptor-related protein 4; Type I cytokine receptor-like factor p48

Inquire Recombinant Human Cytokine receptor-like factor 3 (CRLF3) Now



AbTriva respects your privacy and protects your personal data in accordance with AbTriva. For more information, please see our data protection statement. *

Notification